23 related articles for article (PubMed ID: 6209893)
1. Surgical Approaches for Repigmenting Vitiligo 2.0.
Passeron T
J Invest Dermatol; 2023 Nov; 143(11):2099-2101. PubMed ID: 37436333
[No Abstract] [Full Text] [Related]
2. Trichloroacetic Acid Cautery for Repigmenting Nonresponsive Vitiligo on Lips.
Mukhtar M
J Cutan Aesthet Surg; 2023; 16(2):154-155. PubMed ID: 37554674
[No Abstract] [Full Text] [Related]
3. Langerhans' cells are depleted in chronic graft versus host disease.
Aractingi S; Gluckman E; Dauge-Geffroy MC; Le Goué C; Flahaut A; Dubertret L; Carosella E
J Clin Pathol; 1997 Apr; 50(4):305-9. PubMed ID: 9215146
[TBL] [Abstract][Full Text] [Related]
4. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
[TBL] [Abstract][Full Text] [Related]
5. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
[TBL] [Abstract][Full Text] [Related]
6. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
[TBL] [Abstract][Full Text] [Related]
7. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR+/T6- Langerhans cells of the human cornea.
Seto SK; Gillette TE; Chandler JW
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1719-22. PubMed ID: 3498703
[TBL] [Abstract][Full Text] [Related]
9. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
Claudy AL; Rouchouse B
Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
[TBL] [Abstract][Full Text] [Related]
10. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
Löning T; Caselitz J; Seifert G; Weber K; Osborn M
Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
[TBL] [Abstract][Full Text] [Related]
11. Comments on the isolation and enrichment of human Langerhans cells for use in immunological studies.
Pollack MS; Goldenhersh MA; Chin-Louie J; Safai B
Surv Immunol Res; 1982; 1(3):290-6. PubMed ID: 6764846
[No Abstract] [Full Text] [Related]
12. Monoclonal anti-T6 antibody and Langerhans cells.
Murphy GF
Br J Dermatol; 1982 Oct; 107(4):487-9. PubMed ID: 6751370
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
